Board director since 1 February 2018
Michel began his career at the multinational banking division of Continental Illinois National Bank of Chicago, before spending 18 years with Dow Chemical in several finance functions. He was the chief financial officer Europe of Baxter International from 2002 to 2005 and chief financial officer at ABB Group from 2005 to 2013, before moving to Syngenta AG, where he was chairman of the board until 2017. He was also independent vice chairman at UBS Group from 2009 to 2019.
He is currently a board member of Louis Dreyfus Company Holdings BV, the vice chairman of the supervisory board of the IMD Business School in Lausanne, a non-executive director of AstraZeneca PLC and an advisory board member of the Department of Banking and Finance at the University of Zurich. He holds a degree in applied economics from the Université Catholique de Louvain and an MBA from the Katholieke Universiteit Leuven.
Audit and Risk Committee Remuneration Committee